LVS Δ capB -vectored multiantigenic melioidosis vaccines protect against lethal respiratory Burkholderia pseudomallei challenge in highly sensitive BALB/c mice.

Michael V TulliusRichard A BowenPeter S BackSaša Masleša-GalićSusana NavaMarcus A Horwitz

Published in: mBio (2024)

; this vector platform has previously been used successfully to develop potent vaccines against other Tier 1 select agent diseases including tularemia, anthrax, and plague.

Keyphrases

adipose tissue
high fat diet induced
high throughput
fluorescent probe
type diabetes
anti inflammatory
molecularly imprinted
living cells
respiratory tract
mass spectrometry
high resolution